Pill before the knife: new hope for head and neck cancer patients
NCT ID NCT07254962
Summary
This study is testing if giving patients a short course of an oral chemotherapy pill called capecitabine before their cancer surgery can lead to better results. The goal is to shrink tumors faster, make surgery less complex, and improve long-term survival for people with newly diagnosed, advanced head and neck cancer. About 75 patients will be randomly assigned to receive either this new pre-surgery treatment or the current standard of care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.